Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily TDF/FTC-based PrEP in high-risk Toronto MSM
NCT02149888Phase 4Completed
- Sponsor
- Unity Health Toronto
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Unity Health Toronto. Started Oct 2014; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02149888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02149888.